Menu
Not yet recruiting NCT06663085

Using NIRS to Evaluate Splanchnic Oxygenation During Blood Transfusion in Preterm Infant

No phase Interventional Splanchnic Oxygenation NIRS PreTerm Neonate Enteral Feeds

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Enteral feeding.
Who it may be relevant to
Registry conditions: Splanchnic Oxygenation, NIRS, PreTerm Neonate, Enteral Feeds. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Indonesia
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

The Effect of Enteral Feeding on Splanchnic Oxygenation During Blood Transfusion in Preterm Infants

Overview

To evaluate the differences splanchnic oxygen saturation in preterm infants receiving red blood cell transfusion with and without enteral feeding, and their outcomes.

Detailed description

using NIRS to evaluate splanchnic oxygenation

Interventions

  • Dietary supplement Enteral feeding
    intervention group received enteral feeding breastmilk during transfusion

Primary outcome measures

  • cerebral splanchnic oxygenation ratio using nirs [Time frame: from enrollment to 48 hours after transfusion]

Eligibility criteria

Inclusion criteria

  • Infant with gestational age < 37 weeks
  • Planned to receive blood transfusion
  • Had received minimum 25 ml/kg/day enteral feeding
  • in stable condition

Exclusion criteria

  • Infant with multiple congenital anomalies
  • Infant with suspected/confirmed genetic anomalies
  • Parents or family did not sign the informed consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Single group
Masking
Open label
Primary purpose
Prevention

Study locations

Indonesia · 1 center
  • Dr Sardjito General Hospital — Yogyakarta

Identifiers

NCT: NCT06663085 · KE/FK/1583/EC/2024

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗